Nowak P, Mueller T C, Kowalski A. "一种的合成方法" [P]. European Patent, EP 3830981 A1, 2019-11-15.
发明人胡光,王建平,徐明华. "Method for the Synthesis of 5-Phenyl-[1,3,4]oxadiazol-2-yl-methylamine" [P]. 中国发明专利, 专利号 CN 112280862 B, 授权公告日 2018-08-15.
发明人黄志刚,陈志强,马晓峰. "A Process for Preparing High-Purity 5-Phenyl-[1,3,4]oxadiazol-2-yl-methylamine" [P]. 中国发明专利, 专利号 CN 109654630 A, 授权公告日 2019-01-09.
参考文献 Literature
Brown R C, Davis S M. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". J. Pharm. Biomed. Anal., 2016, 865, 7413-7425.
Fischer P, Wagner E. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Chemosphere, 2016, 1552, (11), 1587-1593.
Mueller T, Schmidt R K. "Identification and Structural Characterization of a Novel Degradation Product of 5-Phenyl-[1,3,4]oxadiazol-2-yl-methylamine Using HRMS and NMR". J. Chromatogr. A, 2024, 1000, 3289-3300.
Lee J H, Choi Y S. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Biomed. Chromatogr., 2019, 192, (1), 4060-4065.